Ampicillin and amoxicillin

Alasdair M. Geddes, Ian M. Gould, Jason A. Roberts, M. Lindsay Grayson, Sara Cosgrove

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Ampicillin and ampicillin-like agents, such as amoxicillin, have many similar properties, but also some important differences. They are all semisynthetic penicillins derived from the penicillin nucleus, but differ in their bioavailability and pharmacokinetic features. The two key agents in this group are ampicillin and amoxicillin, in terms of both their individual properties and the fact that they have both been combined with the beta-lactamase inhibitors, sulbactam (see Chapter 15, Ampicillin-sulbactam) and clavulanic acid (see Chapter 14, Amoxicillin-clavulanic acid), respectively, to broaden their antibacterial spectrum of activity. Ampicillin and amoxicillin will be discussed in detail in this chapter, but information regarding the other, now unused ampicillin-like compounds is summarized in Table 5.1 because they have no special advantages over ampicillin/amoxicillin.

Original languageEnglish (US)
Title of host publicationKucers the Use of Antibiotics
Subtitle of host publicationA Clinical Review of Antibacterial, Antifungal, Antiparasitic, and Antiviral Drugs, Seventh Edition
PublisherCRC Press
Pages100-135
Number of pages36
ISBN (Electronic)9781498747967
ISBN (Print)9781498747950
DOIs
StatePublished - Jan 1 2017

Fingerprint

Amoxicillin
Ampicillin
Penicillins
Sulbactam
Amoxicillin-Potassium Clavulanate Combination
Clavulanic Acid
Biological Availability
Pharmacokinetics

ASJC Scopus subject areas

  • Medicine(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Geddes, A. M., Gould, I. M., Roberts, J. A., Lindsay Grayson, M., & Cosgrove, S. (2017). Ampicillin and amoxicillin. In Kucers the Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic, and Antiviral Drugs, Seventh Edition (pp. 100-135). CRC Press. https://doi.org/10.1201/9781315152110

Ampicillin and amoxicillin. / Geddes, Alasdair M.; Gould, Ian M.; Roberts, Jason A.; Lindsay Grayson, M.; Cosgrove, Sara.

Kucers the Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic, and Antiviral Drugs, Seventh Edition. CRC Press, 2017. p. 100-135.

Research output: Chapter in Book/Report/Conference proceedingChapter

Geddes, AM, Gould, IM, Roberts, JA, Lindsay Grayson, M & Cosgrove, S 2017, Ampicillin and amoxicillin. in Kucers the Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic, and Antiviral Drugs, Seventh Edition. CRC Press, pp. 100-135. https://doi.org/10.1201/9781315152110
Geddes AM, Gould IM, Roberts JA, Lindsay Grayson M, Cosgrove S. Ampicillin and amoxicillin. In Kucers the Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic, and Antiviral Drugs, Seventh Edition. CRC Press. 2017. p. 100-135 https://doi.org/10.1201/9781315152110
Geddes, Alasdair M. ; Gould, Ian M. ; Roberts, Jason A. ; Lindsay Grayson, M. ; Cosgrove, Sara. / Ampicillin and amoxicillin. Kucers the Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic, and Antiviral Drugs, Seventh Edition. CRC Press, 2017. pp. 100-135
@inbook{826cb33d58954d588a55aeb6d4e29358,
title = "Ampicillin and amoxicillin",
abstract = "Ampicillin and ampicillin-like agents, such as amoxicillin, have many similar properties, but also some important differences. They are all semisynthetic penicillins derived from the penicillin nucleus, but differ in their bioavailability and pharmacokinetic features. The two key agents in this group are ampicillin and amoxicillin, in terms of both their individual properties and the fact that they have both been combined with the beta-lactamase inhibitors, sulbactam (see Chapter 15, Ampicillin-sulbactam) and clavulanic acid (see Chapter 14, Amoxicillin-clavulanic acid), respectively, to broaden their antibacterial spectrum of activity. Ampicillin and amoxicillin will be discussed in detail in this chapter, but information regarding the other, now unused ampicillin-like compounds is summarized in Table 5.1 because they have no special advantages over ampicillin/amoxicillin.",
author = "Geddes, {Alasdair M.} and Gould, {Ian M.} and Roberts, {Jason A.} and {Lindsay Grayson}, M. and Sara Cosgrove",
year = "2017",
month = "1",
day = "1",
doi = "10.1201/9781315152110",
language = "English (US)",
isbn = "9781498747950",
pages = "100--135",
booktitle = "Kucers the Use of Antibiotics",
publisher = "CRC Press",
address = "United States",

}

TY - CHAP

T1 - Ampicillin and amoxicillin

AU - Geddes, Alasdair M.

AU - Gould, Ian M.

AU - Roberts, Jason A.

AU - Lindsay Grayson, M.

AU - Cosgrove, Sara

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Ampicillin and ampicillin-like agents, such as amoxicillin, have many similar properties, but also some important differences. They are all semisynthetic penicillins derived from the penicillin nucleus, but differ in their bioavailability and pharmacokinetic features. The two key agents in this group are ampicillin and amoxicillin, in terms of both their individual properties and the fact that they have both been combined with the beta-lactamase inhibitors, sulbactam (see Chapter 15, Ampicillin-sulbactam) and clavulanic acid (see Chapter 14, Amoxicillin-clavulanic acid), respectively, to broaden their antibacterial spectrum of activity. Ampicillin and amoxicillin will be discussed in detail in this chapter, but information regarding the other, now unused ampicillin-like compounds is summarized in Table 5.1 because they have no special advantages over ampicillin/amoxicillin.

AB - Ampicillin and ampicillin-like agents, such as amoxicillin, have many similar properties, but also some important differences. They are all semisynthetic penicillins derived from the penicillin nucleus, but differ in their bioavailability and pharmacokinetic features. The two key agents in this group are ampicillin and amoxicillin, in terms of both their individual properties and the fact that they have both been combined with the beta-lactamase inhibitors, sulbactam (see Chapter 15, Ampicillin-sulbactam) and clavulanic acid (see Chapter 14, Amoxicillin-clavulanic acid), respectively, to broaden their antibacterial spectrum of activity. Ampicillin and amoxicillin will be discussed in detail in this chapter, but information regarding the other, now unused ampicillin-like compounds is summarized in Table 5.1 because they have no special advantages over ampicillin/amoxicillin.

UR - http://www.scopus.com/inward/record.url?scp=85056685232&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056685232&partnerID=8YFLogxK

U2 - 10.1201/9781315152110

DO - 10.1201/9781315152110

M3 - Chapter

AN - SCOPUS:85056685232

SN - 9781498747950

SP - 100

EP - 135

BT - Kucers the Use of Antibiotics

PB - CRC Press

ER -